Gaithersburg, MD, (February 28, 2017) – Sigma-Tau Pharmaceuticals, Inc., a leader in the development and commercialization of medicines for patients with rare diseases, today announced that the company has changed…
You are now leaving the Leadiant Biosciences, Inc. U.S. website and entering the Leadiant German website. Leadiant Biosciences, Inc., is not responsible for its affiliates’ content.
You are now leaving the Leadiant Biosciences, Inc. U.S. website and entering the Leadiant Biosciences Ltd. website. Leadiant Biosciences, Inc., is not responsible for its affiliates’ content.
You are now leaving the Leadiant Biosciences, Inc. U.S. website and entering the Leadiant Biosciences Ltd. website. Leadiant Biosciences, Inc., is not responsible for its affiliates’ content.
You are now leaving the Leadiant Biosciences, Inc. U.S. website and entering the Leadiant Biosciences, Inc. Canada website. The information is intended for Canadian audiences only.
Cookies are pieces of data created when you visit a website. They are stored on your computer and are sent back to the website or to another website that recognizes the cookie. For more information please refer to our Cookie Policy.Click here to accept these terms
